Yesterday, the Department of Health and Human Services (HHS) announced a significant move in the fight against hepatitis C. With $100 million in funding now available, initiatives aimed at testing, treating, and preventing hepatitis C have the opportunity to make a real impact. This announcement comes on the heels of a powerful series by Nick Florko in 2022, titled Death Sentence, which shed light on the dire situation in state prisons where individuals with hepatitis C were being denied testing and treatment. Despite the existence of a cure for hepatitis C, the condition claimed the lives of twice as many incarcerated individuals in 2019 compared to the general population in the United States.
In another development, the National Institutes of Health (NIH) has implemented a new policy that is causing a stir in the research community. The policy reduces the number of grant awards, particularly for R01 grants, which are crucial for funding research at universities and medical centers. This change is expected to have a significant impact, with the National Cancer Institute projecting that only 4% of grant applications will be funded, down from the previous 9%.
For more details on this story and other important health and medical news, be sure to subscribe to STAT’s free newsletter Morning Rounds for your daily dose of information. Stay informed and up-to-date on the latest developments in the field of medicine and health.
This information highlights the ongoing efforts to combat hepatitis C and the challenges faced in securing funding for vital research projects. It underscores the importance of continued support for initiatives that aim to improve public health and advance medical knowledge.
